跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Takeda Pharmaceuticals International Ag Ireland Branch
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 18, 2024
Approval ID
f9f1061fbd37a277
Company
Takeda Pharmaceuticals International Ag Ireland Branch
Type
Standard
Approval Details
Approval Id
f9f1061fbd37a277
Drug Cima Aemps Name
TAKHZYRO 150 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1181340007
Holder Company Name
Takeda Pharmaceuticals International Ag Ireland Branch
Marketing Company Name
Takeda Farmaceutica Espana S.A.
Holder Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Authorization Date
2024-01-18
Dosage Form
SOLUCIÓN INYECTABLE
Dose
150 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Takeda Pharmaceuticals International Ag Ireland Branch
Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Company Information
Pharmaceutical Company Name
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE, 63 - 16
Active Ingredients
LANADELUMAB
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 18, 2024
Approval ID
f9f1061fbd37a277
Type
Standard
Back to CIMA-AEMPS Approvals